ICOS-Expressing Lymphocytes Promote Resolution of CD8-Mediated Lung Injury in a Mouse Model of Lung Rejection

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wu, Qiang ^a   Gardiner, Gail J ^a   Berry, Elizabeth ^b   Wagner, Sarah R ^a   Lu, Tiffany ^b   Clay, Bryan S ^b   Moore, Tamson V ^b   Ferreira, Caroline M ^b   Williams, Jesse W ^b   Luster, Andrew D ^c   Medoff, Benjamin D ^c   Cannon, Judy L ^b   Sperling, Anne I ^b   Shilling, Rebecca A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INDUCIBLE T CELL COSTIMULATOR; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE LUNG INJURY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG MECHANISM; HUMAN VERSUS ANIMAL COMPARISON; INFLAMMATION; LUNG GRAFT REJECTION; LYMPHOCYTE FUNCTION; MOUSE; NEUTROPHIL; NONHUMAN; REGULATORY T LYMPHOCYTE; RESPIRATORY EPITHELIUM; SURVIVAL;

ANIMALS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GRAFT REJECTION; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-2; LUNG INJURY; LUNG TRANSPLANTATION; LYMPHOCYTE SUBSETS; MICE; NEUTROPHILS; T-LYMPHOCYTES, REGULATORY;

EID: 84881491533     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072955     Document Type: Article

References (54)

1. Small BA, Dressel SA, Lawrence CW, Drake DR 3rd, Stoler MH, et al. (2001) CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells. J Exp Med 194: 1835-1846. doi:10.1084/jem.194.12.1835. PubMed: 11748284.
2. Clelland C, Higenbottam T, Stewart S, Otulana B, Wreghitt T, et al. (1993) Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am Rev Respir Dis 147: 1386-1392. doi:10.1164/ajrccm/147.6_Pt_1.1386. PubMed: 8503549.
3. Crim C, Keller CA, Dunphy CH, Maluf HM, Ohar JA, (1996) Flow cytometric analysis of lung lymphocytes in lung transplant recipients. Am J Respir Crit Care Med 153: 1041-1046. doi:10.1164/ajrccm.153.3.8630543. PubMed: 8630543.
4. Gregson AL, Hoji A, Saggar R, Ross DJ, Kubak BM, et al. (2008) Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. Transplantation 85: 1056-1059. doi:10.1097/TP.0b013e318169bd85. PubMed: 18408589.
5. Whitehead BF, Stoehr C, Finkle C, Patterson G, Theodore J, et al. (1995) Analysis of bronchoalveolar lavage from human lung transplant recipients by flow cytometry. Respir Med 89: 27-34. doi:10.1016/0954-6111(95)90067-5. PubMed: 7708976.
6. Hodge G, Hodge S, Li-Liew C, Chambers D, Hopkins P, et al. (2010) Time post-lung transplant correlates with increasing peripheral blood T cell granzyme B and proinflammatory cytokines. Clin Exp Immunol 161: 584-590. doi:10.1111/j.1365-2249.2010.04186.x. PubMed: 20528884.
7. Hodge G, Hodge S, Chambers D, Reynolds PN, Holmes M, (2007) Acute lung transplant rejection is associated with localized increase in T-cell IFNgamma and TNFalpha proinflammatory cytokines in the airways. Transplantation 84: 1452-1458. doi:10.1097/01.tp.0000290679.94163.e1. PubMed: 18091521.
8. Gelman AE, Okazaki M, Lai J, Kornfeld CG, Kreisel FH, et al. (2008) CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J Immunol 180: 4754-4762. PubMed: 18354199.
9. Boros P, Bromberg JS, (2009) Human FOXP3+ regulatory T cells in transplantation. Am J Transplant 9: 1719-1724. doi:10.1111/j.1600-6143.2009.02704.x. PubMed: 19538489.
10. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336. doi:10.1038/ni904. PubMed: 12612578.
11. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. doi:10.1126/science.1079490. PubMed: 12522256.
12. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164. PubMed: 7636184.
13. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, et al. (2006) Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. J Heart Lung Transplant 25: 880-892. doi:10.1016/j.healun.2006.06.001. PubMed: 16890108.
14. Wilkes DS, Egan TM, Reynolds HY, (2005) Lung transplantation: opportunities for research and clinical advancement. Am J Respir Crit Care Med 172: 944-955. doi:10.1164/rccm.200501-098WS. PubMed: 16020804.
15. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, et al. (2005) Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353: 2342-2351. doi:10.1056/NEJMoa051907. PubMed: 16319383.
16. Martinu T, Howell DN, Palmer SM, (2010) Acute cellular rejection and humoral sensitization in lung transplant recipients. Semin Respir Crit Care Med 31: 179-188. doi:10.1055/s-0030-1249113. PubMed: 20354931.
17. Wood KJ, Sakaguchi S, (2003) Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3: 199-210. doi:10.1038/nri1027. PubMed: 12658268.
18. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG, (2001) B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2: 1126-1132. doi:10.1038/ni735. PubMed: 11702067.
19. Bhorade SM, Chen H, Molinero L, Liao C, Garrity ER, et al. (2010) Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 90: 540-546. doi:10.1097/00007890-201007272-01007. PubMed: 20628341.
20. Bour-Jordan H, Bluestone JA, (2009) Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 229: 41-66. doi:10.1111/j.1600-065X.2009.00775.x. PubMed: 19426214.
21. Read S, Malmström V, Powrie F, (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192: 295-302. doi:10.1084/jem.192.2.295. PubMed: 10899916.
22. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, et al. (2000) Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192: 303-310. doi:10.1084/jem.192.2.303. PubMed: 10899917.
23. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, et al. (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193: 1285-1294. doi:10.1084/jem.193.11.1285. PubMed: 11390435.
24. Sánchez-Fueyo A, Weber M, Domenig C, Strom TB, Zheng XX, (2002) Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 168: 2274-2281. PubMed: 11859115.
25. Kingsley CI, Karim M, Bushell AR, Wood KJ, (2002) CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168: 1080-1086. PubMed: 11801641.
26. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440. doi:10.1016/S1074-7613(00)80195-8. PubMed: 10795741.
27. Salomon B, Bluestone JA, (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19: 225-252. doi:10.1146/annurev.immunol.19.1.225. PubMed: 11244036.
28. Burmeister Y, Lischke T, Dahler AC, Mages HW, Lam KP, et al. (2008) ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol 180: 774-782. PubMed: 18178815.
29. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, et al. (2008) Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28: 870-880. doi:10.1016/j.immuni.2008.03.018. PubMed: 18513999.
30. Vocanson M, Rozieres A, Hennino A, Poyet G, Gaillard V, et al. (2010) Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells. J Allergy Clin Immunol 126: 280-289.e281-287 doi:10.1016/j.jaci.2010.05.022. PubMed: 20624644.
31. Fulton RB, Meyerholz DK, Varga SM, (2010) Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol 185: 2382-2392. doi:10.4049/jimmunol.1000423. PubMed: 20639494.
32. Medoff BD, Seung E, Wain JC, Means TK, Campanella GS, et al. (2005) BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J Exp Med 202: 97-110. doi:10.1084/jem.20042481. PubMed: 15998790.
33. Grabie N, Delfs MW, Westrich JR, Love VA, Stavrakis G, et al. (2003) IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest 111: 671-680. doi:10.1172/JCI16867. PubMed: 12618521.
34. Shilling RA, Clay BS, Tesciuba AG, Berry EL, Lu T, et al. (2009) CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo. Cell Immunol 259: 177-184. doi:10.1016/j.cellimm.2009.06.013. PubMed: 19646680.
35. Thornton AM, Piccirillo CA, Shevach EM, (2004) Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 34: 366-376. doi:10.1002/eji.200324455. PubMed: 14768041.
36. Seung E, Cho JL, Sparwasser T, Medoff BD, Luster AD, (2011) Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection. J Immunol 186: 6830-6838. doi:10.4049/jimmunol.1001049. PubMed: 21555535.
37. Malek TR, Yu A, Scibelli P, Lichtenheld MG, Codias EK, (2001) Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J Immunol 166: 1675-1683. PubMed: 11160210.
38. Manjunath N, Shankar P, Wan J, Weninger W, Crowley MA, et al. (2001) Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest 108: 871-878. doi:10.1172/JCI200113296. PubMed: 11560956.
39. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, et al. (2010) Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32: 79-90. doi:10.1016/j.immuni.2009.11.012. PubMed: 20096607.
40. Kalia V, Sarkar S, Subramaniam S, Haining WN, Smith KA, et al. (2010) Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32: 91-103. doi:10.1016/j.immuni.2009.11.010. PubMed: 20096608.
41. Dummer W, Ernst B, LeRoy E, Lee D, Surh C, (2001) Autologous regulation of naive T cell homeostasis within the T cell compartment. J Immunol 166: 2460-2468. PubMed: 11160306.
42. D'Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, et al. (2009) CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 119: 2898-2913. doi:10.1172/JCI36498. PubMed: 19770521.
43. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE, (2008) Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83: 64-70. PubMed: 17884993.
44. Dunay IR, Fuchs A, Sibley LD, (2010) Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice. Infect Immun 78: 1564-1570. doi:10.1128/IAI.00472-09. PubMed: 20145099.
45. Shi C, Hohl TM, Leiner I, Equinda MJ, Fan X, et al. (2011) Ly6G+ neutrophils are dispensable for defense against systemic Listeria monocytogenes infection. J Immunol 187: 5293-5298. doi:10.4049/jimmunol.1101721. PubMed: 21976773.
46. Clay BS, Shilling RA, Bandukwala HS, Moore TV, Cannon JL, et al. (2009) Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells. PLOS ONE 4: e7525. doi:10.1371/journal.pone.0007525. PubMed: 19888475.
47. Moore TV, Clay BS, Cannon JL, Histed A, Shilling RA, et al. (2011) Inducible costimulator controls migration of T cells to the lungs via down-regulation of CCR7 and CD62L. Am J Respir Cell Mol Biol 45: 843-850. doi:10.1165/rcmb.2010-0466OC. PubMed: 21421907.
48. Kornete M, Sgouroudis E, Piccirillo CA, (2012) ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol 188: 1064-1074. doi:10.4049/jimmunol.1101303. PubMed: 22227569.
49. Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, et al. (2012) IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 129: 207-215 e201-205 doi:10.1016/j.jaci.2011.08.009. PubMed: 21906794.
50. Chen Y, Shen S, Gorentla BK, Gao J, Zhong XP, (2012) Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression. J Immunol 188: 1698-1707. doi:10.4049/jimmunol.1102448. PubMed: 22231701.
51. Redpath SA, van der Werf N, Cervera AM, MacDonald AS, Gray D, et al. (2013) ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection. Eur J Immunol 43: 705-715. doi:10.1002/eji.201242794. PubMed: 23319295.
52. Miyamoto K, Kingsley CI, Zhang X, Jabs C, Izikson L, et al. (2005) The ICOS molecule plays a crucial role in the development of mucosal tolerance. J Immunol 175: 7341-7347. PubMed: 16301640.
53. Bonhagen K, Liesenfeld O, Stadecker MJ, Hutloff A, Erb K, et al. (2003) ICOS+ Th cells produce distinct cytokines in different mucosal immune responses. Eur J Immunol 33: 392-401. doi:10.1002/immu.200310013. PubMed: 12645936.
54. Löhning M, Hutloff A, Kallinich T, Mages HW, Bonhagen K, et al. (2003) Expression of ICOS In Vivo Defines CD4(+) Effector T Cells with High Inflammatory Potential and a Strong Bias for Secretion of Interleukin 10. J Exp Med 197: 181-193. doi:10.1084/jem.20020632. PubMed: 12538658.